September 07, 2018
1 min read
Save

Trial Scorecard: SHOCK-COOL

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers assessed whether use of mild therapeutic hypothermia would improve cardiac power index and other outcomes in patients with STEMI and cardiogenic shock.

Trial Scorecard: SHOCK-COOL